Current innovative treatments of obesity

Obesity is a complex and pervasive chronic health concern with multifaceted origins in which abnormal or excessive fat accumulation worsens health, increases the risk of long-term medical complications and shortens life expectancy. It is associated with type 2 diabetes, non-alcoholic fatty liver dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Damian Wach (Author), Aneta Głaz (Author), Jolanta Wiśniewska (Author), Zuzanna Radziejowska (Author)
Format: Book
Published: Kazimierz Wielki University, 2023-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6ba33cb6d41b45c9b5c202850480949f
042 |a dc 
100 1 0 |a Damian Wach  |e author 
700 1 0 |a Aneta Głaz  |e author 
700 1 0 |a Jolanta Wiśniewska  |e author 
700 1 0 |a Zuzanna Radziejowska  |e author 
245 0 0 |a Current innovative treatments of obesity 
260 |b Kazimierz Wielki University,   |c 2023-10-01T00:00:00Z. 
500 |a 10.12775/JEHS.2023.21.01.020 
500 |a 2391-8306 
520 |a Obesity is a complex and pervasive chronic health concern with multifaceted origins in which abnormal or excessive fat accumulation worsens health, increases the risk of long-term medical complications and shortens life expectancy. It is associated with type 2 diabetes, non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease. More than 603.7 million adults are estimated to be obese. The cause of obesity is a long-term energy imbalance caused by a combination of increased energy intake and decreased energy expenditure. The purpose of this study is to analyze the effectiveness of modern obesity treatments such as intermittent fasting, semaglutide and surgical interventions. Intermittent fasting involves voluntary periods of restricted or zero caloric intake at specified intervals. However, research results on the effectiveness of this dietary strategy are conflicting. The findings indicate that incorporating physical exercise can further enhance the outcomes of applying this diet. Semaglutide, a GLP-1 (glucagon-like peptide-1) analog, has shown efficacy in promoting weight loss among adults and adolescents, along with metabolic and cardiovascular improvements. Laparoscopic sleeve gastrectomy (LSG) is a common bariatric procedure, while Roux-en-Y gastric bypass (LRYGB) is another option. Long-term studies show that both methods effectively promote weight loss. In conclusion, obesity is a multifaceted condition that requires a comprehensive treatment approach. Individualized strategies including dietary changes, pharmaceutical interventions such as semaglutide, and surgical options can together contribute to effective weight management and improved health outcomes. 
546 |a EN 
546 |a ES 
546 |a PL 
546 |a RU 
546 |a UK 
690 |a obesity 
690 |a diet 
690 |a semaglutide 
690 |a intermittent fasting 
690 |a Education 
690 |a L 
690 |a Sports 
690 |a GV557-1198.995 
690 |a Medicine 
690 |a R 
655 7 |a article  |2 local 
786 0 |n Journal of Education, Health and Sport, Vol 21, Iss 1 (2023) 
787 0 |n https://apcz.umk.pl/JEHS/article/view/46096 
787 0 |n https://doaj.org/toc/2391-8306 
856 4 1 |u https://doaj.org/article/6ba33cb6d41b45c9b5c202850480949f  |z Connect to this object online.